The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy

被引:16
|
作者
Oda, Michael N. [1 ]
Budamagunta, Madhu S. [2 ]
Borja, Mark S. [1 ]
Petrlova, Jitka [3 ]
Voss, John C. [2 ]
Lagerstedt, Jens O. [3 ]
机构
[1] Childrens Hosp Oakland Res Inst, Oakland, CA USA
[2] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA
[3] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden
基金
瑞典研究理事会;
关键词
apolipoproteinA-I (ApoA-I); cardiovascular; cholesterol; EPR spectroscopy; high-density lipoprotein (HDL); LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PARAMAGNETIC-RESONANCE SPECTROSCOPY; CRYSTAL-STRUCTURE; APOA-I; MASS-SPECTROMETRY; TERMINAL DOMAIN; N-TERMINUS; SITE; HDL; CONFORMATION;
D O I
10.1111/febs.12334
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ApolipoproteinA-I (ApoA-I) is the major protein component of high-density lipoprotein (HDL), and is critical for maintenance of cholesterol homeostasis. During reverse cholesterol transport, HDL transitions between an array of subclasses, differing in size and composition. This process requires ApoA-I to adapt to changes in the shape of the HDL particle, transiting from an apolipoprotein to a myriad of HDL subclass-specific conformations. Changes in ApoA-I structure cause alterations in HDL-specific enzyme and receptor-binding properties, and thereby direct the HDL particle through the reverse cholesterol transport pathway. In this study, we used site-directed spin label spectroscopy to examine the conformational details of the ApoA-I central domain on HDL. The motional dynamics and accessibility to hydrophobic/hydrophilic relaxation agents of ApoA-I residues99-163 on 9.6-nm reconstituted HDL was analyzed by EPR. In previous analyses, we examined residues6-98 and 164-238 (of ApoA-I's 243 residues), and combining these findings with the current results, we have generated a full-length map of the backbone structure of reconstituted HDL-associated ApoA-I. Remarkably, given that the majority of ApoA-I's length is composed of amphipathic helices, we have identified nonhelical residues, specifically the presence of a -strand (residues149-157). The significance of these nonhelical residues is discussed, along with the other features, in the context of ApoA-I function in contrast to recent models derived by other methods.
引用
收藏
页码:3416 / 3424
页数:9
相关论文
共 50 条
  • [1] DEFINED APOLIPOPROTEIN A-I CONFORMATIONS IN RECONSTITUTED HIGH-DENSITY LIPOPROTEIN DISKS
    JONAS, A
    KEZDY, KE
    WALD, JH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (09) : 4818 - 4824
  • [2] Structure of apolipoprotein A-I on high-density lipoprotein subclasses
    Cavigiolio, Giorgio
    Geier, Ethan G.
    Chandradas, Sajiv H.
    Budamagunta, Madhu
    Voss, John C.
    Oda, Michael N.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E128 - E128
  • [3] Structure and function of apolipoprotein A-I and high-density lipoprotein
    Segrest, JP
    Li, L
    Anantharamaiah, GM
    Harvey, SC
    Liadaki, KN
    Zannis, V
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (02) : 105 - 115
  • [4] High-density lipoprotein subclasses and apolipoprotein A-I
    Duriez, P
    Fruchart, JC
    CLINICA CHIMICA ACTA, 1999, 286 (1-2) : 97 - 114
  • [5] Characterization of reconstituted high-density lipoprotein containing apolipoprotein A-I deletion mutants.
    Smyth, N
    Almarez, R
    Galvan-Rueckert, F
    Brouillette, CG
    Engler, JA
    Roberts, LM
    BIOCHEMISTRY, 2000, 39 (06) : 1569 - 1569
  • [6] High-density lipoprotein apolipoprotein A-I kinetics in obesity
    Ooi, EMM
    Watts, GF
    Farvid, MS
    Chan, DC
    Allen, MC
    Zilko, SR
    Barrett, PHR
    OBESITY RESEARCH, 2005, 13 (06): : 1008 - 1016
  • [7] High-Density Lipoprotein/Apolipoprotein A-I Infusion Therapy
    Tardif, Jean-Claude
    Heinonen, Therese
    Noble, Stephane
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (01) : 58 - 63
  • [8] Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles
    Nguyen, David
    Nickel, Margaret
    Mizuguchi, Chiharu
    Saito, Hiroyuki
    Lund-Katz, Sissel
    Phillips, Michael C.
    BIOCHEMISTRY, 2013, 52 (11) : 1963 - 1972
  • [9] Apolipoprotein A-I mimetics and high-density lipoprotein function
    Gordon, Scott M.
    Davidson, William S.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2012, 19 (02) : 109 - 114
  • [10] High-density lipoprotein/apolipoprotein A-I infusion therapy
    Jean-Claude Tardif
    Therese Heinonen
    Stephane Noble
    Current Atherosclerosis Reports, 2009, 11 : 58 - 63